Last reviewed 2026-04-23 · How we verify

Glucon-D 99.4% (Placebo)

Glucon-D 99.4% is a glucose supplement that provides rapid carbohydrate absorption to raise blood glucose levels in hypoglycemic states.

Glucon-D 99.4% is a glucose supplement that provides rapid carbohydrate absorption to raise blood glucose levels in hypoglycemic states. Used for Hypoglycemia management, Acute glucose supplementation in diabetes.

At a glance

Mechanism of action

Glucon-D is a dextrose (glucose) monohydrate formulation designed for rapid oral glucose replacement. It is absorbed quickly through the gastrointestinal tract to elevate blood glucose concentrations in patients experiencing hypoglycemia or requiring acute carbohydrate supplementation. As a placebo formulation in this Phase 3 trial, the 99.4% specification likely refers to the purity of the glucose component.

Approved indications

• Hypoglycemia management
• Acute glucose supplementation in diabetes

Common side effects

• Hyperglycemia (if overdosed)
• Gastrointestinal discomfort

Key clinical trials

• Effect of Lactoferrin on Polio Seroconversion (NA)
• Bovine Lactoferrin and Neonatal Survival in Low Birth Weight Babies. (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Glucon-D 99.4% (Placebo) CI brief — competitive landscape report
• Glucon-D 99.4% (Placebo) updates RSS · CI watch RSS
• Aga Khan University portfolio CI